| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 727.98B | 671.89B | 598.43B | 541.58B | 495.57B | 556.04B |
| Gross Profit | 111.80B | 92.92B | 71.19B | 60.14B | 56.72B | 55.15B |
| EBITDA | 85.44B | 68.06B | 49.80B | 40.78B | 38.08B | 37.29B |
| Net Income | 56.73B | 42.38B | 27.34B | 21.17B | 20.32B | 20.15B |
Balance Sheet | ||||||
| Total Assets | 644.20B | 603.22B | 567.27B | 495.87B | 478.57B | 464.83B |
| Cash, Cash Equivalents and Short-Term Investments | 77.48B | 60.99B | 66.65B | 65.23B | 72.61B | 63.48B |
| Total Debt | 34.56B | 27.11B | 27.27B | 15.78B | 15.80B | 16.63B |
| Total Liabilities | 229.06B | 222.27B | 221.47B | 187.41B | 185.05B | 185.37B |
| Stockholders Equity | 400.57B | 367.86B | 333.94B | 298.40B | 283.98B | 270.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.38B | 1.57B | 2.00B | 19.91B | 7.12B |
| Operating Cash Flow | 0.00 | 18.26B | 19.84B | 7.46B | 27.15B | 12.87B |
| Investing Cash Flow | 0.00 | -10.17B | -19.08B | -6.63B | -9.22B | -972.00M |
| Financing Cash Flow | 0.00 | -12.63B | 567.00M | -7.32B | -7.79B | -26.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥257.94B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
74 Outperform | ¥595.64B | 13.52 | 8.34% | 2.66% | 5.14% | 12.52% | |
72 Outperform | ¥1.29T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥696.70B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
70 Outperform | ¥545.20B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |